For adults with moderate to severe rheumatoid arthritis (RA) in whom TNF blockers did not work well.

If you’re still experiencing RA symptoms after a TNF blocker like HUMIRA® or ENBREL®,

RINVOQ is

Different

and may help

RINVOQ is a JAK inhibitor

For adults with moderate to severe rheumatoid arthritis (RA) in whom TNF blockers did not work well.

Proven in clinical studies, RINVOQ can:

  • Tame joint pain, swelling, and stiffness

  • Stop further irreversible joint damage

  • Make it easier to do everyday things

  • Significantly reduce fatigue

RINVOQ Bottle and Once-Daily Pill

RINVOQ is a once-daily
pill, not an injection

Select Important Safety Information

RINVOQ may cause serious side effects, including:

  • Serious Infections, Cancer and Immune System Problems, and Blood Clots.
  • Increased risk of death in people age 50+ with at least 1 heart disease risk factor.
  • Increased risk of major cardiovascular events, such as heart attack, stroke, or death in people age 50+ with at least 1 heart disease risk factor, especially in current or past smokers.
  • Serious allergic reactions. Do not take if allergic to RINVOQ or its ingredients.

Learn more about these and other serious side effects >

See full Important Safety Information below.

HUMIRA® is a registered trademark of AbbVie Inc. ENBREL® (etanercept) is a registered trademark of Immunex Corporation in the US.

FACTS ABOUT RINVOQ

People have been prescribed RINVOQ for RA in the US since 2019

RA clinical trial experience

>95% of people with insurance are covered for RINVOQ

>95% of people with self- or employer-provided insurance plans or Medicare Part D are covered for RINVOQ. National Commercial and Medicare Part D formulary coverage as of June 2023.

Meet people
taking RINVOQ

Hear how real patients stand up
to RA with RINVOQ.

Clipboard Icon

Get Mission Ready

Create your game plan to take on RA with tools that will help you assess your symptoms, set goals for the future, and prepare for your next rheumatologist appointment.

Are you getting relief?

If you haven’t seen significant improvement in your RA pain, swelling, and stiffness after 3 months with your current treatment, it may be time for a treatment change.

To see how RA is affecting you, take the RA disease activity assessment today >

RINVOQ Digital Brochure

Read up on RINVOQ

The RINVOQ digital brochure is your go-to guide to taking on rheumatoid arthritis.

Book Icon

Share your RINVOQ story

Share your experience with RINVOQ to help inform and inspire others. To participate, please email us at info@SPEAKnetwork.net or call 877-861-6180.

ENBREL® (etanercept) is a registered trademark of Immunex Corporation in the US.